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Introduction
Selenium, an important micronutrient, has been implicated in reducing the incidence of cancer in different animal models and human clinical trials [I-31. As discussed in many chapters in this book, this trace element is incorporated into proteins in the form of selenocysteine and is often present at the active centers of selenium-containing enzymes. This chapter describes one such protein, designated the 1 5 -kDa selenoprotein (Sep 1 5). Sep 1 5 was identified in 1998 by purifLing and characterizing a protein fiom human T cells [4] . This protein was subsequently implicated in the cancer prevention effect of dietary selenium [5] , and more recently in regulation of redox homeostasis in the endoplasmic reticulum (ER) [6] . This chapter provides up to date information on Sepl5 and members of its family.
Potential role of SeplS in cancer prevention
Several selenoproteins have been proposed as candidates that are responsible for the cancer prevention potential of selenium. Among these proteins is Sepl5 that has been implicated in mediating the chemopreventive effect of selenium in certain types of cancers, including liver [5] , prostate [7] , breast 181, and lung malignancies [9]. The following lines of evidence make an argument for a possible role of Sepl5 in cancer etiology. The human gene encoding Sepl5 is located on chromosome 1 at position p31, a locus commonly deleted or mutated in human cancers and implicated in tumor suppression [ 10,111. Sep 15 expression was found to be significantly decreased in more than half of the tested cancer samples and tumor cell lines as compared to corresponding controls [5, 9] . Genetic analysis of the human Sepl5 gene revealed the presence of two polymorphisms that show strong allelic association [5] . These two single nucleotide polymorphisms (SNPs) are located at positions 8 1 1 (C/T) and 1 125 (GIA) in the Sep 15 mRNA (see Figure 1) . The latter polymorphism is, in fact, part of the SECIS element, an RNA structure in the 3'-untranslated region required for recognition of in-frame UGA codons as selenocysteine. This SNP appears to influence expression of Sepl5 in a selenium-dependent manner. The A1125 variant resulted in a higher expression of the selenoprotein, but it could not efficiently respond to the addition of selenium in the cell culture medium [5, 7, 12] . Thus, this SNP directly influenced the expression levels of Sepl5, and the outcome was dependent on the selenium status. These data suggested that individuals differing in these alleles may not only differ in Sepl5 levels but also in the response to selenium dietary supplements. The polymorphisms have further relevance to cancer. The A1 125 form is prevalent in African Americans who are known to have a higher incidence of prostate cancer [7] . It also should be noted that the highest expression of Sepl5 is observed in the prostate [5] . It is conceivable that African Americans require higher levels of selenium to achieve the protective levels of Sepl5 expression. In addition, it was found that African Americans showed differences in allelic frequency in head, neck, and breast cancers and examples of the loss of heterozygosity at the Sep 15 locus also were observed [7] .
Recent studies from other groups provide further evidence in support of these observations. For example, the A1 125 form was found to be less responsive than the G1125 form to the selenium that showed growth inhibitory and apoptotic effects [9] .
Interaction of Sepl5 with UDP-glucose:glycoprotein glucosyltransferase
During initial purification from a human T-cell line, Sepl5 was isolated in the denatured state [4]; however, native Sepl5 isolated from rat prostate and mouse liver co-purified with a protein of -160-240 kDa. The binding partner of Sepl5 was identified as UDP-glucose:glycoprotein glucosyltransferase (UGT), an ER chaperone and essential regulator of the calnexin cycle [6] . The calnexin cycle is a quality control pathway localized to the ER that specifically assists in the folding of N-linked glycoproteins [13] . In this quality control pathway, UGT functions as the folding sensor that recognizes unfolded or improperly folded glycoproteins (Figure 2) . UGT catalyzes the transfer of a glucose moiety from UDP-glucose to the glycan core [14] that creates a retention signal and initiates binding of membrane-bound calnexin and its lumenal homologue calreticulin to the glycan [15- 181. This triggers the binding of ERp57 (a lurnenal protein disulfide isomerase) to calnexin and calreticulin, and accelerates folding by catalyzing disulfide bond exchange . The tight association of Sepl5 and UGT in 1 : 1 ratio (with apparent Kd of 20 nM) suggests that this selenoprotein may modulate the enzymatic activity of UGT and/or be involved in assessing structural fidelity [24] . This role is also supported by the observation that expression of Sepl5 is activated by the unfolded protein response (UPR), a signaling pathway activated in response to accumulation of unfolded proteins in the ER [25] . The W R pathway results in enhanced expression of genes encoding proteins that facilitate protein folding and help cells remove incorrectly folded and/or excess proteins in the ER. Sequence analysis of the Sepl5 family members identified two distinct domains within this selenoprotein: a C-terminal thioredoxin-like domain that contains the redox active CxU motif and a novel cysteine-rich domain located in the N-terminal part of the protein (Figure 3) . The latter domain exclusively mediates the interaction with UGT and contains six cysteine residues, which are highly conserved among Sepl5 proteins. In contrast to Sepl 5 , this domain is absent in its homologue selenoprotein M (SelM), and SelM does not interact with UGT. Mutational studies have shown that substitution of any of the six conserved cysteine residues with serines disrupts the interaction between Sepl5 and UGT. As four of these six cysteines form a pair of CwrC motifs, there was a possibility that these motifs were involved in coordination of metal ions. However, neither cysteine-rich domain itself coordinated metal ions, nor was the formation of Sepl 5-UGT complex mediated by metals [24] suggesting that these conserved cysteine residues likely form intramolecular disulfide bonds. Site-directed mutagenesis of cysteine residues may disrupt proper arrangement of the Consistent with the ER localization of UGT, SeplS was also localized to the ER, and its N-terminal signal peptide, which was cleaved in the mature protein, was necessary for the ER translocation [6] . In contrast, the Cterminus of SeplS lacked a typical ER retention signal suggesting that location of Sepl5 in this cellular compartment is the result of the interaction with UGT via the N-terminal cysteine-rich domain.
Thiol-disulfide oxidoreductase function
The solution NMR structures of the thioredoxin-like domain of SeplS fiom Drosophila melanogaster and SelM fiom Mus musculus have been identified [26] . The structural studies revealed that both Sepl5 and SelM have a thioredoxin-like fold and suggested a thiol-disulfide oxidoreductase function for these selenoproteins. Although the precise biological function of Sepl5 remains unknown, its surface-accessible CxU motif, located in the Cterminal redox domain, may participate in the reduction, isomerization or oxidation of disulfide bonds and facilitate protein folding (Figure 2) . The redox potential of Drosophila Sepl5, which naturally encodes a cysteine residue in place of the selenocysteine in the redoxactive CxU motif, was measured to be -225 mV. This redox potential is higher than that of the strong disulfide reductant thioredoxin (-270 mV [27, 28] ), but is lower than that of the dithiol oxidase DsbA (-122 rnV [29, 30] ). However, the redox potential of SeplS is within the range of the redox potentials of disulfide reshuffling enzymes, such as PDI (-1 75 mV [27] ), indicating that Sepl 5 may fbnction as a disulfide isomerase. Although the measured redox potential is close to that of the protein disulfide isomerase, the possibility cannot be excluded that biological activity of Sepl5 in vivo may be affected by proteinprotein interactions with other ER resident proteins and available donors/acceptors of electrons. Furthermore, in contrast to protein disulfide isomerase and its broad substrate specificity, Sepl5 may service a restricted group of protein substrates as demonstrated for protein disulfide isomerase ERp57, which functions exclusively as an isomerase for partially folded glycoproteins that are bound to the chaperones calnexin and calreticulin [19,22,3 11 . In this case, UGT, which recognizes improperly folded glycoproteins, may serve as a primary binding site for Sepl5 protein substrates (analogous to the role of non-catalytic bt-domain of human protein disul fide isomerase).
Expression pattern and regulation of Sepl5 expression by dietary selenium
Expression of the Sepl5 gene was examined in several mouse and human tissues by northern blot and immunoblot analyses [5] . The highest levels of gene expression were observed in prostate, liver, kidney, testes and brain, while lower levels were found in lung, spleen and skeletal muscle.
Dietary selenium has been shown to regulate the expression of selenoproteins and the abundance of corresponding mRNAs by acting at both transcriptional and translational levels. For example, selenium deficiency is known to result in up to a 99% decrease in the activity of glutathione peroxidase 1 (GPxl) and in up to a 90% decrease in the abundance of GPxl mRNA in livers of rats and mice. Similar to GPxl, Sepl5 expression was also regulated by selenium availability in liver and kidney, although the changes in expression were less pronounced [26, 32] . In contrast, Sepl5 expression in testes remained almost constant regardless of the selenium availability, consistent with previous observations that the expression patterns of selenoproteins localized to the liver and kidney are highly responsive to the availability of selenium, while the testes efficiently retain this element under selenium-deficient conditions [33, 34] .
Sepl5 selenoprotein family members
Sepl5 is highly conserved from plants to humans [4] suggesting an evolutionary conserved physiological function among Sep 1 5 proteins. Another ER resident eukaryotic selenoprotein, SelM, a distant homolog of Sepl 5, has recently been identified and characterized [35] . SelM and Sepl5 share 31% sequence identity in their proposed redox-active domains and encode an N-terminal signal peptide (see Figure 3) , which is cleaved in the mature protein after translocation into the ER. In contrast to Sepl5, the cysteine-rich UGT-binding domain is absent in SelM, and SelM is likely retained in the ER by a C-terminal retention signal (H/R/K-X-DL). This selenoprotein shows a different expression pattern than Sep 15, with the highest expression in the brain. Although the function of SelM has not been firmly established, recent studies provide evidence that decreased expression of this protein is associated with Alzheimer's disease and SelM may be involved in protection of neurons from oxidative damage [36] .
Recently, a new selenoprotein distantly homologous to Sepl5 family members has been identified [37] . This selenoprotein was found only in fish and was designated Fepl5 (for fish SeplS-like protein). As observed with SelM, Fepl5 contains a known ER retention signal (RDEL) at its C-terminus and was also localized to the ER. Fepl5 encodes a single selenocysteine residue. In contrast to Sepl5, in which Sec is organized into highly conserved CxU motif, and SelM, in which Sec is present within CsucU motif, FeplS has valine in place of the conserved cysteine. Moreover, Fepl5 does not have any conserved cysteine residues, and in some of the FeplS sequences cysteines are not present at all. Thus, this selenoprotein has a distinct catalytic mechanism that may involve formation of selenenic acid or selenenylsulfide bond with a cysteine residue in another protein or low molecular weight thiol, such as glutathione 1381. Another unique feature of this novel selenoprotein is that it is present exclusively in selenocysteinecontaining form, while other members of the SeplS protein family exist in the form of both selenocysteine-and cysteine-containing proteins. Furthermore, the very narrow distribution of Fepl5 among fishes suggests that this protein may have a highly specialized function.
